The glycemic control of secondary diabetes, either through a hygienic–dietetic regime, oral antidiabetics or insulin therapy, is largely managed according to the same rules and principles as the therapy for primary forms of diabetes. The gene discussed is INS; the disease is diabetes mellitus.